ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
62 690,69
-0,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Codex DNA Inc (DNAY)

  7. Codex DNA Inc (DNAY) Actualités

DNAY

Codex DNA (DNAY)

Codex DNA Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:DNAY
DateHeureSourceTitreSymboleSociété
20/06/202322h11Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DNAYCodex DNA Inc
15/06/202322h19Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:DNAYCodex DNA Inc
09/06/202322h48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNAYCodex DNA Inc
09/06/202300h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNAYCodex DNA Inc
09/06/202300h10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DNAYCodex DNA Inc
24/05/202322h35Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DNAYCodex DNA Inc
17/05/202322h08Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:DNAYCodex DNA Inc
19/04/202312h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DNAYCodex DNA Inc
24/03/202321h02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DNAYCodex DNA Inc
22/03/202311h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DNAYCodex DNA Inc
14/02/202319h10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNAYCodex DNA Inc
09/01/202315h00GlobeNewswire Inc.Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial ResultsNASDAQ:DNAYCodex DNA Inc
09/11/202212h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DNAYCodex DNA Inc
08/11/202222h10GlobeNewswire Inc.Telesis Bio Inc. Reports Third Quarter 2022 Financial ResultsNASDAQ:DNAYCodex DNA Inc
02/11/202221h19GlobeNewswire Inc.Telesis Bio to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 8NASDAQ:DNAYCodex DNA Inc
19/10/202215h00GlobeNewswire Inc.Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrumentNASDAQ:DNAYCodex DNA Inc
12/10/202215h00GlobeNewswire Inc.Codex DNA Announces Plan to Change Corporate Name to Telesis BioNASDAQ:DNAYCodex DNA Inc
04/10/202215h00GlobeNewswire Inc.Codex DNA Expands Application of Proprietary Error Correction TechnologyNASDAQ:DNAYCodex DNA Inc
26/09/202213h00GlobeNewswire Inc.Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, NetherlandsNASDAQ:DNAYCodex DNA Inc
19/09/202213h00GlobeNewswire Inc.Codex DNA Debuts Next-Generation Automated Synthetic Biology WorkstationNASDAQ:DNAYCodex DNA Inc
22/08/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DNAYCodex DNA Inc
09/08/202222h10GlobeNewswire Inc.Codex DNA Reports Second Quarter 2022 Financial ResultsNASDAQ:DNAYCodex DNA Inc
02/08/202222h05GlobeNewswire Inc.Codex DNA to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022NASDAQ:DNAYCodex DNA Inc
26/07/202222h13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:DNAYCodex DNA Inc
13/06/202214h45TipRanksCodex DNA (DNAY) Receives a Rating Update from a Top AnalystNASDAQ:DNAYCodex DNA Inc
02/06/202214h03GlobeNewswire Inc.Codex DNA to Present at the 2022 Jefferies Healthcare ConferenceNASDAQ:DNAYCodex DNA Inc
01/06/202214h03GlobeNewswire Inc.Codex DNA Showcases Automated Synthetic Biology Solutions for Accelerating Discovery Workflows at the Antibody Engineering and Therapeutics Europe ConferenceNASDAQ:DNAYCodex DNA Inc
10/05/202222h05GlobeNewswire Inc.Codex DNA Reports First Quarter 2022 Financial ResultsNASDAQ:DNAYCodex DNA Inc
03/05/202214h03GlobeNewswire Inc.Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022NASDAQ:DNAYCodex DNA Inc
29/04/202215h20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DNAYCodex DNA Inc
 Showing the most relevant articles for your search:NASDAQ:DNAY

Dernières Valeurs Consultées

NASDAQ
NVDA
NVIDIA
EU
ACA
Credit Agricole
EU
GLE
Societe Generale
NASDAQ
GOOGL
Alphabet
EU
CAP
Capgemini
EU
CS
Axa
EU
VK
Vallourec
SPI
SP500
S&P 500
USI
USTECH100
US Tech 100
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
FTSE
UKX
FTSE 100
EU
RNO
Renault
EU
SGO
Cie de SaintGobain
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés